BERGAMINI, ALICE
 Distribuzione geografica
Continente #
EU - Europa 4.788
AS - Asia 2.693
NA - Nord America 2.341
SA - Sud America 493
AF - Africa 42
OC - Oceania 12
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.371
Nazione #
US - Stati Uniti d'America 2.231
RO - Romania 1.749
RU - Federazione Russa 1.700
SG - Singapore 933
CN - Cina 834
IT - Italia 519
BR - Brasile 408
HK - Hong Kong 250
VN - Vietnam 238
SE - Svezia 234
BD - Bangladesh 158
FR - Francia 121
DE - Germania 117
GB - Regno Unito 95
IN - India 80
NL - Olanda 55
CA - Canada 50
FI - Finlandia 50
MX - Messico 42
AR - Argentina 41
ES - Italia 38
JP - Giappone 34
PL - Polonia 31
TR - Turchia 30
ID - Indonesia 25
AT - Austria 20
ZA - Sudafrica 20
IE - Irlanda 18
IQ - Iraq 15
PK - Pakistan 14
LT - Lituania 11
MY - Malesia 11
EC - Ecuador 10
BE - Belgio 9
CO - Colombia 8
JO - Giordania 7
MA - Marocco 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
CL - Cile 6
IL - Israele 6
PH - Filippine 6
QA - Qatar 6
SA - Arabia Saudita 6
UA - Ucraina 6
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
EG - Egitto 4
JM - Giamaica 4
KR - Corea 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
CH - Svizzera 3
IR - Iran 3
KZ - Kazakistan 3
NI - Nicaragua 3
PY - Paraguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
KW - Kuwait 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.371
Città #
Singapore 467
Dallas 419
Moscow 357
Ashburn 317
San Jose 284
Hong Kong 249
Beijing 154
New York 146
Milan 144
Shanghai 140
Hefei 94
Ho Chi Minh City 87
Los Angeles 87
Lauterbourg 84
Hanoi 59
Lawrence 46
Munich 46
Princeton 46
São Paulo 44
Boardman 42
Orem 39
Santa Clara 38
Rome 32
Chennai 29
Warsaw 28
Denver 27
Tokyo 27
Turku 26
Bergamo 25
Vaprio d'Adda 25
Nuremberg 24
London 22
Council Bluffs 21
Boston 20
The Dalles 20
Amsterdam 19
Manchester 19
Mexico City 19
Montreal 19
Brooklyn 18
Dublin 18
Brescia 17
Haiphong 17
Helsinki 17
Houston 17
Frankfurt am Main 16
Poplar 16
Seattle 16
Stockholm 16
Columbus 15
Johannesburg 15
Atlanta 14
Rio de Janeiro 14
St Petersburg 13
Toronto 13
Florence 12
Phoenix 12
Buffalo 11
Cesano Boscone 10
Guangzhou 10
Mumbai 10
Naples 10
Pune 10
Rho 10
Shenzhen 10
Tianjin 10
Ankara 9
Chicago 9
Gatchina 9
Querétaro 9
Valencia 9
Belo Horizonte 8
Charlotte 8
Istanbul 8
New Delhi 8
Paris 8
San Francisco 8
Turin 8
Vienna 8
Bari 7
Brussels 7
Kuala Lumpur 7
Lappeenranta 7
Tashkent 7
Xi'an 7
Biên Hòa 6
Brasília 6
Campinas 6
Da Nang 6
Doha 6
Falkenstein 6
Fortaleza 6
Trieste 6
Amman 5
Baghdad 5
Curitiba 5
Dalmine 5
Lima 5
Philadelphia 5
Porto Alegre 5
Totale 4.392
Nome #
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 406
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 378
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 367
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 362
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 348
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 332
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 271
Additional value of uterine artery Doppler pulsatility index for ultrasound diagnosis of placental site trophoblastic tumor: prospective cohort study 236
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 227
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 224
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 193
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 149
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 144
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 138
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 136
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 132
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 131
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 130
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 126
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 126
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 124
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 121
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 116
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 116
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 115
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group 115
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 113
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 112
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 110
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 105
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 102
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 102
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 101
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 100
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 99
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 98
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 96
Psychological aspects and fertility issues of GTD 95
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 94
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 92
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 92
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 91
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 89
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 89
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 85
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 83
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 83
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 81
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 81
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 79
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 78
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 77
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 76
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 76
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 75
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 75
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 75
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 74
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 74
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 74
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 71
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 70
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 70
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 70
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 69
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 67
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 67
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 67
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 67
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 66
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 65
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 65
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 65
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 64
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 61
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 60
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 58
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 57
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 57
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 57
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 57
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 57
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 56
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 56
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 56
Ovarian endometrioma: what the patient needs 54
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 54
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 54
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 53
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 51
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 51
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 51
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 51
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 48
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 48
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 48
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 48
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 47
Fertility preservation in women with cervical cancer 46
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 34
Totale 10.602
Categoria #
all - tutte 45.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 1 1 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/20253.377 141 35 64 51 89 130 1.955 162 259 158 139 194
2025/20266.043 455 335 511 764 520 191 541 440 1.466 308 258 254
Totale 10.635